New combo treatment aims to halt Kids' rapidly worsening eyesight

NCT ID NCT06523504

Summary

This study is testing whether using low-dose atropine eye drops together with special 'DIMS' spectacle lenses can better slow the progression of moderate to high nearsightedness in children aged 6-12. Researchers want to see if this combination is more effective than using either treatment alone at controlling eye elongation and vision changes. The trial will enroll 410 children across multiple centers to compare the safety and effectiveness of different treatment approaches.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tianjin Medical University Eye Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 120120, China

    Contact

Conditions

Explore the condition pages connected to this study.